Remedy’s investor relations are coordinated by Veli-Pekka Puolakanaho, Corporate Development Director.

Investor meetings and statements issued by the company are subject to a silent period of 30 days preceding the publication of a business review, a half-year review or a financial statements release.

Veli-Pekka Puolakanaho
Corporate Development Director
+358 50 430 0936

Tero Virtala
Chief Executive Officer
+358 9 435 5040

General requests